Thierry Paper
Fondatore presso BIOSYNEX
Patrimonio netto: 1 M $ in data 30/06/2024
Profilo
Mr. Thierry Paper is a Director, Deputy CEO-Research & Development at Biosynex SA, a Marketing Manager at Orgenics Ltd.
and a Manager at Axodev SARL.
He is on the Board of Directors at Chembio Diagnostics, Inc., Theradiag SA, Biosynex SA and Biosynex Swiss SA. He received his MBA from Ecole Nationale des Ponts et Chaussées.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOSYNEX SA
3.62% | 31/12/2022 | 389 988 ( 3.62% ) | 1 M $ | 30/06/2024 |
Posizioni attive di Thierry Paper
| Società | Posizione | Inizio |
|---|---|---|
| BIOSYNEX | Fondatore | 15/03/2005 |
| THERADIAG | Direttore/Membro del Consiglio | 05/05/2022 |
| CHEMBIO DIAGNOSTICS, INC. | Direttore/Membro del Consiglio | 27/04/2023 |
| Axodev SARL | Corporate Officer/Principal | - |
Orgenics Ltd.
 Orgenics Ltd. Medical SpecialtiesHealth Technology Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel. | Vendite & Marketing | 01/01/1990 |
| Biosynex Swiss SA | Direttore/Membro del Consiglio | - |
Formazione di Thierry Paper
| Ecole Nationale des Ponts et Chaussées | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOSYNEX | Health Technology |
| Aziende private | 5 |
|---|---|
| Axodev SARL | |
Orgenics Ltd.
Orgenics Ltd. Medical SpecialtiesHealth Technology Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel. | Health Technology |
| Biosynex Swiss SA | |
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
Chembio Diagnostics, Inc.
 Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
- Borsa valori
- Insiders
- Thierry Paper
